Casein kinase 2α regulates multidrug resistance-associated protein 1 function via phosphorylation of Thr249

Molecular Pharmacology

Volumn 82, Issue 3, 2012, Pages 488-499

  Stolarczyk, Elzbieta I ^a   Reiling, Cassandra J ^a   Pickin, Kerry A ^a,b   Coppage, Ryan ^c   Knecht, Marc R ^c   Paumi, Christian M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b CENTRE COLLEGE   (United States)

^c Department of Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,5,6,7 TETRABROMO 2 DIMETHYLAMINO 1H BENZIMIDAZOLE; ALANINE; CASEIN KINASE 2 ALPHA; CASEIN KINASE II; DOXORUBICIN; ESTRADIOL 17 GLUCURONIDE; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN MCF 7; CELL VACUOLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG SENSITIVITY; ENZYME REGULATION; GENE INACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; TISSUE CULTURE;

BIOLOGICAL TRANSPORT; CASEIN KINASE II; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; HUMANS; LEUKOTRIENE C4; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; PHOSPHORYLATION;

EID: 84865257568     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.078295     Document Type: Article

References (51)

1. Ausubel FM, Brent R, Kingston RE, Moore FF, Seidman JG, Smith JA, and Struhl K (1987) Current Protocols in Molecular Biology, Greene Publishing Associates/Wiley Interscience, New York.
2. Bakos E, Evers R, Calenda G, Tusnády GE, Szakács G, Váradi A, and Sarkadi B (2000) Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1). J Cell Sci 113:4451-4461.
3. Burnett G and Kennedy EP (1954) The enzymatic phosphorylation of proteins. J Biol Chem 211:969-980.
4. Campling BG, Pym J, Baker HM, Cole SP, and Lam YM (1991) Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer 63:75-83.
5. Campling BG, Pym J, Galbraith PR, and Cole SP (1988) Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. Leuk Res 12:823-831.
6. Chambers SH, Bleehen NM, and Watson JV (1984) Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells. Br J Cancer 49:301-306.
7. Chambers TC, Pohl J, Glass DB, and Kuo JF (1994) Phosphorylation by protein kinase C and cyclic AMP-dependent protein kinase of synthetic peptides derived from the linker region of human P-glycoprotein. Biochem J 299:309-315.
8. Chappe V, Hinkson DA, Zhu T, Chang XB, Riordan JR, and Hanrahan JW (2003) Phosphorylation of protein kinase C sites in NBD1 and the R domain control CFTR channel activation by PKA. J Physiol 548:39-52.
9. Chen ZS and Tiwari AK (2011) Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases. FEBS J 278:3226-3245.
10. Cole SP (1986) Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol 17:259-263.
11. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654.
12. Di Maira G, Brustolon F, Bertacchini J, Tosoni K, Marmiroli S, Pinna LA, and Ruzzene M. Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level. Oncogene 26(48):6915-6926, 2007.
13. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, and Ross DD (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95:15665-15670.
14. Duncan JS and Litchfield DW (2008) Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim Biophys Acta 1784:33-47.
15. Fernández SB, Holló Z, Kern A, Bakos E, Fischer PA, Borst P, and Evers R (2002) Role of the N-terminal transmembrane region of the multidrug resistance protein MRP2 in routing to the apical membrane in MDCKII cells. J Biol Chem 277:31048-31055.
16. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SP, and Deeley RG (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54:357-361.
17. Hunter T and Sefton BM (1991) Protein Phosphorylation, Academic Press, San Diego.
18. Juliano RL and Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152-162.
19. Keppler D, Jedlitschky G, and Leier I (1998) Transport function and substrate specificity of multidrug resistance protein. Methods Enzymol 292:607-616.
20. Keppler D, Leier I, and Jedlitschky G (1997) Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 378:787-791.
21. Kramerov AA, Saghizadeh M, Caballero S, Shaw LC, Li Calzi S, Bretner M, Montenarh M, Pinna LA, Grant MB, and Ljubimov AV (2008) Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites. Mol Cell Biochem 316:177-186.
22. Lautier D, Canitrot Y, Deeley RG, and Cole SP (1996) Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochemical pharmacology 52:967-977.
23. Litchfield DW (2003) Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 369:1-15.
24. Loe DW, Almquist KC, Cole SP, and Deeley RG (1996) ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J Biol Chem 271:9683-9689.
25. Mason DL and Michaelis S (2002) Requirement of the N-terminal extension for vacuolar trafficking and transport activity of yeast Ycf1p, an ATP-binding cassette transporter. Molecular biology of the cell 13:4443-4455.
26. Meggio F and Pinna LA (2003) One-thousand-and-one substrates of protein kinase CK2? FASEB J 17:349-368.
27. Mishra S, Pertz V, Zhang B, Kaur P, Shimada H, Groffen J, Kazimierczuk Z, Pinna LA, and Heisterkamp N (2007) Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2. Leukemia 21:178-180.
28. Moon TE (1980) Quantitative and statistical analysis of the association between in vitro and in vivo studies. Prog Clin Biol Res 48:209-221.
29. Moon TE, Salmon SE, White CS, Chen HS, Meyskens FL, Durie BG, and Alberts DS (1981) Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapy. Cancer Chemother Pharmacol 6:211-218.
30. Munoz M, Henderson M, Haber M, and Norris M (2007) Role of the MRP1/ABCC1 multidrug transporter protein in cancer. IUBMB Life 59:752-757.
31. Nooter K, Westerman AM, Flens MJ, Zaman GJ, Scheper RJ, van Wingerden KE, Burger H, Oostrum R, Boersma T, and Sonneveld P (1995) Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1:1301-1310.
32. Olsten ME, Canton DA, Zhang C, Walton PA, and Litchfield DW (2004) The Pleckstrin homology domain of CK2 interacting protein-1 is required for interactions and recruitment of protein kinase CK2 to the plasma membrane. J Biol Chem 279:42114-42127.
33. Pagano MA, Marin O, Cozza G, Sarno S, Meggio F, Treharne KJ, Mehta A, and Pinna LA (2010) Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2. Biochem J 426:19-29.
34. Pagano MA, Meggio F, Ruzzene M, Andrzejewska M, Kazimierczuk Z, and Pinna LA (2004) 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2. Biochem Biophys Res Commun 321:1040-1044.
35. Paumi CM, Chuk M, Chevelev I, Stagljar I, and Michaelis S (2008) Negative regulation of the yeast ABC transporter Ycf1p by phosphorylation within its N-terminal extension. J Biol Chem 283:27079-27088.
36. Paumi CM, Chuk M, Snider J, Stagljar I, and Michaelis S (2009) ABC transporters in Saccharomyces cerevisiae and their interactors: new technology advances the biology of the ABCC (MRP) subfamily. Microbiol Mol Biol Rev 73:577-593.
37. Paumi CM, Ledford BG, Smitherman PK, Townsend AJ, and Morrow CS (2001) Role of multidrug resistance protein 1 (MRP1) and glutathione S-transferase A1-1 in alkylating agent resistance. Kinetics of glutathione conjugate formation and efflux govern differential cellular sensitivity to chlorambucil versus melphalan toxicity. J Biol Chem 276:7952-7956.
38. Paumi CM, Wright M, Townsend AJ, and Morrow CS (2003) Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. Biochemistry 42:5429-5437.
39. Pickin KA, Ezenwajiaku N, Overcash H, Sethi M, Knecht MR, and Paumi CM (2010) Suppression of Ycf1p function by Cka1p-dependent phosphorylation is attenuated in response to salt stress. FEMS Yeast Res 10:839-857.
40. Roelofsen H, Vos TA, Schippers IJ, Kuipers F, Koning H, Moshage H, Jansen PL, and Müller M (1997) Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells. Gastroenterology 112:511-521.
41. Ruzzene M and Pinna LA (2010) Addiction to protein kinase CK2: a common denominator of diverse cancer cells? Biochim Biophys Acta 1804:499-504.
42. Seeber S, Issinger OG, Holm T, Kristensen LP, and Guerra B (2005) Validation of protein kinase CK2 as oncological target. Apoptosis 10:875-885.
43. Seldin DC, Lou DY, Toselli P, Landesman-Bollag E, and Dominguez I (2008) Gene targeting of CK2 catalytic subunits. Mol Cell Biochem 316:141-147.
44. Stolarczyk EI, Reiling CJ, and Paumi CM (2011) Regulation of ABC transporter function via phosphorylation by protein kinases. Curr Pharm Biotechnol 12:621-635.
45. Trembley JH, Chen Z, Unger G, Slaton J, Kren BT, Van Waes C, and Ahmed K (2010) Emergence of protein kinase CK2 as a key target in cancer therapy. Biofactors 36:187-195.
46. Villén J, Beausoleil SA, Gerber SA, and Gygi SP (2007) Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci USA 104:1488-1493.
47. Wang H, Davis A, Yu S, and Ahmed K (2001) Response of cancer cells to molecular interruption of the CK2 signal. Mol Cell Biochem 227:167-174.
48. Xue Y, Ren J, Gao X, Jin C, Wen L, and Yao X (2008) GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Mol Cell Proteomics 7:1598-1608.
49. Yamane K and Kinsella TJ (2005) CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation. Cancer Res 65:4362-4367.
50. Yang Y, Liu Y, Dong Z, Xu J, Peng H, Liu Z, and Zhang JT (2007) Regulation of function by dimerization through the amino-terminal membrane-spanning domain of human ABCC1/MRP1. J Biol Chem 282:8821-8830.
51. Yang Y, Mo W, and Zhang JT (2010) Role of transmembrane segment 5 and extracellular loop 3 in the homodimerization of human ABCC1. Biochemistry 49:10854-10861.